🇺🇸 FDA
Patent

US 8618074

GPCR enhanced neuroprotection to treat brain injury

granted A61KA61K31/7072A61P

Quick answer

US patent 8618074 (GPCR enhanced neuroprotection to treat brain injury) held by The Board of Regents of the University of Texas System expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/7072, A61P, A61P25/00